Data were collected on four thematic areas: knowledge, attitudes and behaviours; cannabis use and products used; driving and cannabis, and cannabis for medical purposes (Canadian Government)
Archives for December 2017
Bibliography: All Publications
Drug Overdose Deaths in the United States, 1999–2016
Deaths from drug overdose are an increasing public health burden in the United States. This report uses the most recent data from the National Vital Statistics System (NVSS) to update trends in drug overdose deaths, describe demographic and geographic patterns, and identify shifts in the types of drugs involved (CDC)
Substance misuse treatment in secure settings: statistics 2015 to 2016
Alcohol and drug misuse treatment in prisons and other secure settings from PHE’s national drug treatment monitoring system (NDTMS)
Non-medical use of pharmaceuticals: trends, harms and treatment 2006–07 to 2015–16
The non-medical use of pharmaceuticals is common—about 1 million Australians (4.8%) aged 14 years or older reported recent non-medical use of a pharmaceutical drug (AIHW)
National Drug-Related Deaths Index 2004 to 2015 data
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning (overdose) by alcohol and/or other drugs, and deaths among drug users (non-poisoning), in the period 2004–2015 (Health Research Board, Ireland)
Searching for cannabis (PDF)
Are grounds for search associated with outcomes? (College of Policing)
Drug misuse and dependence: UK guidelines on clinical management
How clinicians should treat people with drug misuse and drug dependence problems (DoH)
Minimizing Harm: Public Health and Justice System Responses to Drug Use and the Opioid Crisis (PDF)
How government and communities should respond to drug use is a perennial question that has gained a renewed sense of urgency in the face of the current opioid overdose crisis. More than 52,000 Americans died from a drug overdose in 2015, a number that has grown nearly ninefold since 1980 (Vera Institute of Justice)
Monitoring the Future
Overall, 43,703 students from 360 public and private schools participated in this year’s Monitoring the Future survey. The survey is funded by the NIDA, a component of the National Institutes of Health (NIH)
Reducing the harm associated with drugs of abuse: the role of pharamacists (PDF)
This report represents the outcome of a literature search of a working group, their deliberations and insights (International Pharmaceutical Federation)
Vaping popular among teens; opioid misuse at historic lows
NIH’s 2017 Monitoring the Future survey shows both vaping and marijuana are more popular than traditional cigarettes or pain reliever misuse NIH, USA)
Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS)
1 April 2016 to 31 March 2017 (Public Health England)
National Wastewater Drug Monitoring Program
Wastewater analysis is widely applied internationally as a tool to measure and interpret drug use within national populations. The Australian Government has recognised the considerable benefits of wastewater analysis and has partnered with established scientific expertise within Australian academic institutions to introduce a national program based on international models (Australian Criminal Intelligence Commission)
How illegal drugs sustain organised crime in the EU (PDF)
Drug markets remain the largest criminal markets in the EU. More than one third of the criminal groups active in the EU are involved in the production, trafficking or distribution of various types of drugs (Europol, Belgium)
Health Research Board publish latest drug-related deaths figures
Almost two people died each day in Ireland during 2015 as a result of poisoning, trauma or medical causes linked to drug use according to the latest figures from the Health Research Board (Ireland)
A global picture of injecting drug use, HIV and anti-HCV prevalence among people who inject drugs, and coverage of harm reduction interventions December 2017
The number of people who inject drugs
Women and young people as a proportion of people who inject drugs
HIV and HCV antibody (anti-HCV) prevalence among people who inject drugs
Coverage of needle and syringe programs (NSP) and opioid substitution therapy (OST)
(NDARC)
Developing drug supply monitoring in Europe: current concepts
This paper presents the EMCDDA’s current thinking on the conceptual framework for monitoring drug markets, crime and supply reduction — building on the work completed in this area and expanding to reflect the academic research underpinning this work and the developments observed
Substance misuse treatment for young people: statistics 2016 to 2017
Alcohol and drug treatment data for under-18s from PHE’s national drug treatment monitoring system (NDTMS)
Myanmar Opium Survey
In 2017, the Central Committee for Drug Abuse Control (CCDAC) of the Myanmar Police Force of the Republic of the Union of Myanmar collaborated for the 15th time with the United Nations Office on Drugs and Crime (UNODC) to implement an opium survey
Harm reduction approaches predicted to reduce rates of new hepatitis C infection for people who inject drugs
Needle and syringe exchange appears to be cost-effective, especially if considering the health gains from preventing HIV transmission too. Although the evidence is from observational studies, and the extent of the benefit might uncertain, the nature of the topic makes it difficult to gather evidence in any other way and compared to the cost of treating the consequences of hepatitis later, seems good value (NIHR)